CMRX
Chimerix Inc
No insider bought or sold Chimerix Inc in the last 12 months
CMRX over the last year
Prices for CMRX aren't in yet.
CMRX after insider buys
3 months after each buy, from the first price a copier could get.
4 buys since 2016 with 3 months of prices.
Every filing
27 insider filings since 2016, newest first
Michael T. Andriole · Chief Business Officer and CFO
Michael A. Sherman · CEO
Fred A Middleton · Director
Michael T. Andriole · Chief Business Officer and CFO
David Jakeman · Principal Accounting Officer
Cantex Pharmaceuticals, Inc. · 10% owner
David Jakeman · Principal Accounting Officer
Michael A. Sherman · CEO
Fred A Middleton · Director
Garrett Nichols · Chief Medical Officer
Fred A Middleton · Director
Michael T. Andriole · Chief Business Officer
Martha J Demski · Director
Michael A. Sherman · CEO
Fred A Middleton · Director
M Michelle Berrey · President and CEO
Ernest Mario · Director
Ernest Mario · Director
Ernest Mario · Director
Ernest Mario · Director
Linda M Richardson · Chief Commercial Officer
Ernest Mario · Director
John M. Leonard · Director
Ernest Mario · Director
Ernest Mario · Director
Timothy Wollaeger · Director
Martha J Demski · Director
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.